Week In Review: CStone Pharma To Develop Novel Drugs For China With $150 Million In Startup Capital
July 09, 2016 at 14:28 PM EDT
CStone Pharma, a Shanghai-Suzhou startup, closed a $150 million Series A round to license novel drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.